Ethics and Polices for Publisher

Ethics and Polices for Publisher

 

 

A. PUBLICATION ETHICS

 

BPAS Publication Journals are dedicated to following best practices on ethical matters, errors and retractions. The prevention of publication malpractice is one of the important responsibilities of the editorial board. Any kind of unethical behavior is not acceptable, and BPAS Publication does not tolerate plagiarism in any form. Authors submitting articles to BPAS Publication Journals affirm that manuscript contents are original.

 

As such, BPAS journals follow the COPE Code of Conduct and Best Practice Guidelines for Journal Editors and the Code of Conduct for Journal Publishers.

 

In addition, as a journal that follows the ICMJE’s Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, it is expected of authors, reviewers and editors that they follow the best-practice guidelines on ethical behaviour contained therein.

 

Published statement of Human and Animal Rights

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). If doubt exists whether the research was conducted in accordance with the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

 

Published Statement of Informed Consent

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

 

Conflict of Interest Policy

BPAS Publication recognizes the multiplicity of financial and other conflicts confronting authors, referees, and editors. BPAS Publication adopted a policy in August 2008 that does not aim to eliminate conflict but to manage it. The most important element of our policy is that all authors, members, referees, and editors must disclose any association that poses or could be perceived as a financial or intellectual conflict of interest in connection with the manuscript.

 

Authors are required during submission of their manuscripts to complete the online declaration form, to disclose any conflict of interest, and to acknowledge all funding sources supporting the work. The corresponding author must ensure that all authors have been asked to disclose any conflicts of interest.

 

When asked to evaluate a manuscript, reviewers and editors must disclose any association that poses a conflict of interest in connection with the manuscript. Recent collaborators, defined as people who have coauthored a paper or were a principal investigator on a grant with any of the authors within the past 48 months, must be excluded as editors and reviewers. Referees and editors are asked to recues themselves from handling a paper if the conflict makes them unable to make an impartial scientific judgment or evaluation. A referee or editor who has a conflict but believes that it does not preclude his or her making a proper judgment must disclose to the journal the nature of the conflict.

 

Divulging a potential conflict usually does not invalidate the research or the comments of a referee or editor; it simply provides the reader information necessary to independently assess the work. A conflict of interest includes a financial association or relationship that could influence the objectivity, integrity, or interpretation of a publication. Such conflicts of interest include relationships with corporations whose products or services are related to the subject matter of the article. These relations include employment, substantive ownership of stock or mutual funds, membership on a standing advisory council or committee, service on the board of directors, or public association with the company or its products. Other areas of conflict of interest could include receiving consulting fees, patent filings, serving as a paid spokesperson, or providing services in exchange for honoraria. Other examples of possible conflicts include past or present association as thesis advisor or thesis student, or a family relationship, such as a spouse, domestic partner, or parent–child relationship.

 

When a conflict of interest is disclosed either by the author or editor, a footnote describing the conflict will be included with the published article.

 

BPAS Publication reserves the right to publish an erratum disclosing conflict(s) of interest related to a previously published paper. Authors, referees, or editors who have deliberately or recklessly failed to disclose conflicts of interest may receive sanctions, including being banned from publishing in BPAS Publication for a period of time.

 

This policy applies to all material published in BPAS Publication including research articles, Perspectives, Editorials, Reviews, Colloquium Papers, and Commentaries.

 

B. BPAS PUBLICATION'S POLICY

It is a general principle of scholarly communication that the editor of a learned journal is solely and independently responsible for deciding which articles submitted to the journal shall be published. In making this decision the editor is guided by policies of the journal's editorial board and constrained by such legal requirements in force regarding libel, copyright infringement and plagiarism. An outcome of this principle is the importance of the scholarly archive as a permanent, historic record of the transactions of scholarship. Articles that have been published shall remain extant, exact and unaltered as far as is possible. However, very occasionally circumstances may arise where an article is published that must later be retracted or even removed. Such actions must not be undertaken lightly and can only occur under exceptional circumstances.

BPAS Publications reviewers have a responsibility to report suspected duplicate publication, fraud, plagiarism, or concerns about animal or human experimentation to the Editor. A reviewer may recognize and report that he/she is refereeing, or has recently refereed, a similar or identical paper for another journal by the same author(s). Readers may report that they have seen the same article elsewhere, or authors may see their own published work being plagiarized. In all cases we address ethical concerns diligently following an issue-specific standard practice as summarized below.

 

The first action of the journal Editor is to inform the Editorial Office of BPAS Publications by supplying copies of 1) the relevant material and 2) a draft letter to the corresponding author asking for an explanation in a nonjudgmental manner. The Editorial Office must approve any correspondence before it is sent to the author. If the author’s explanation is unacceptable and it seems that serious unethical conduct has taken place, the matter is referred to the Publication Committee via Editorial Office.  After deliberation, the Committee will decide whether the case is sufficiently serious to warrant a ban on future submissions to, and serving as a reviewer for, BPAS Publications Journals; and/or whether the offending author’s institution should be informed. The decision has to be approved by the Executive Cabinet of the BPAS Publications Council, and the author has the right to appeal a sanction, with the opportunity to present his/her position.

 

If the infraction is less severe, the Editor, upon the advice of the Publication Committee, will send the author a letter of reprimand and remind the author of BPAS Publication policies; if the manuscript has been published, the Editor may require the author to publish an apology in the journal to correct the record. If, through the author’s actions, BPAS Publications has violated the copyright of another journal, the Publication Committee writes a letter of apology to the other journal.

 

In serious cases of fraud that result in retraction of the article, a retraction notice will be published in the journal and will be linked to the article in the online version. The online version will also be marked “retracted” with the retraction date.


This policy has been designed to address these concerns and to take into account current best practice in the scholarly and library communities. As standards evolve and change, we will revisit this issue and welcome the input of scholarly and library communities. We believe these issues require international standards and we will be active in lobbying various information bodies to establish international standards and best practices that the publishing and information industries can adopt.

C. ADVERTISING POLICY

 

•     All advertisements are subject to approval of the BPAS Publication, which reserves the right to reject or cancel any ad at any time.

•     All advertisements are accepted and published by Publisher on the warranty of the agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.

•     In consideration of publication of an advertisement, the advertiser and the agency, jointly and severally, agree to indemnify and hold harmless Publisher, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement or plagiarism.

•     Publisher will not be liable for any failure to publish any advertisement accepted by Publisher; however, Publisher shall use its reasonable efforts to place such advertisement in subsequent available space.

•     All advertisements must clearly and prominently identify the advertiser by trademark or signature.

•     For advertorial guidelines contact your Sales Manager.

•     Any references to Publisher or its products or services in advertisements, promotional material or merchandising by the advertiser or agency are subject to Publisher’s written approval for such use.

•     All advertising contract position clauses are treated as requests. Publisher cannot guarantee fixed positioning.

•     Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an ad.

•     Publisher may change the terms set forth herein at any time, provided that no such change applies to ads whose closing date precedes the announcement of the change.

•     Publisher will not be bound by any condition, printed or otherwise, appearing on any insertion order or copy instructions when such conditions conflict with the conditions set forth in this rate card.

•     In the event of nonpayment, Publisher reserves the right to hold advertiser and/or its advertising agency jointly and severally liable for such monies as are past due and payable to Publisher.

•     Proprietary names of pharmaceutical products must be accompanied by the chemical, generic or official name; the quantity of all active substances must be stated along with the recommended dosage. New ad copy and creative for pharmaceutical products should be sent to the advertising department. Please allow two weeks for clearance.

•     All advertisements must be clearly germane to the practice of medicine.

•     Advertiser represents and warrants that all advertisements and pharmaceutical products they advertise are compliant with all applicable laws, rules, and regulations in the country where the advertisement will be seen. Advertisements for pharmaceutical products (including NDA products) that are subject to India Food and Drug Administration (FDA) oversight must comply with FDA regulations regarding advertising and promotion.

•     Any use of Publisher’s trademarks and its logo design, or copyrighted material for links to and from a Publisher website must be approved in advance by Publisher. Publisher does not endorse or support any product or organization linked to its website, nor is Publisher responsible for the content of any website promoted in any advertisement appearing at a Publisher website.

•     All advertisements at Journal served on article pages are served on a random basis, in rotation with BPAS Publication advertising and recruitment advertising. The random placement algorithm does not permit any commercial ad to be targeted to any specific article or any specific user or groups of users. Advertisers have no advance knowledge of and no control over ad placement. Neither the Publisher nor its publications endorse any company, product, or service.

•     Recruitment ads must be nondiscriminatory and comply with all applicable laws and regulations. Ads that discriminate against applicants based on sex, age, race, religion, marital status or physical handicap will not be accepted. Non-India recruitment advertisers are required to confirm in writing that they are equal opportunity employers.

 

D. ONLINE CANCELLATION POLICIES

 

Advertiser may cancel the entire Insertion Order, or any portion thereof, as follows:

 

Run-Of-Site Banner Programs:

•     On written notice to Publisher given 21 or more days before the start date. With cancellations inside 21 days of the start date, advertiser will be responsible for 50% of the Insertion Order amount that was reserved for delivery.

•     Flat fee-based or fixed placement programs (including, but not limited to, Roadblocks, Specialty Packs, and other Sponsorships:

•     On written notice to Publisher given 30 or more days before the start date. With cancellations inside 30 days of the start date, advertiser will be responsible for 50% of the IO amount that was reserved for delivery.

 

 

E. DUTIES OF EDITORS, REVIEWERS, AUTHORS AND PUBLISHERS

 

DUTIES OF EDITORS

 

Fair play and editorial independence

Editors evaluate submitted manuscripts exclusively on the basis of their academic merit (importance, originality, study’s validity, clarity) and its relevance to the journal’s scope, without regard to the authors’ race, gender, sexual orientation, ethnic origin, citizenship, religious belief, political philosophy or institutional affiliation. Decisions to edit and publish are not determined by the policies of governments or any other agencies outside of the journal itself. The Editor-in-Chief has full authority over the entire editorial content of the journal and the timing of publication of that content.

 

Confidentiality

Editors and editorial staff will not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

 

Disclosure and conflicts of interest

Editors and editorial board members will not use unpublished information disclosed in a submitted manuscript for their own research purposes without the authors’ explicit written consent. Privileged information or ideas obtained by editors as a result of handling the manuscript will be kept confidential and not used for their personal advantage. Editors will recuse themselves from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships/connections with any of the authors, companies or institutions connected to the papers; instead, they will ask another member of the editorial board to handle the manuscript.

 

Publication decisions

The editors ensure that all submitted manuscripts being considered for publication undergo peer-review by at least two reviewers who are expert in the field. The Editor-in-Chief is responsible for deciding which of the manuscripts submitted to the journal will be published, based on the validation of the work in question, its importance to researchers and readers, the reviewers’ comments, and such legal requirements as are currently in force regarding libel, copyright infringement and plagiarism. The Editor-in-Chief may confer with other editors or reviewers in making this decision.

 

Involvement and cooperation in investigations

Editors (in conjunction with the publisher and/or society) will take responsive measures when ethical concerns are raised with regard to a submitted manuscript or published paper. Every reported act of unethical publishing behavior will be looked into, even if it is discovered years after publication. BPAS Publication follow the COPE Flowcharts when dealing with cases of suspected misconduct. If, on investigation, the ethical concern is well-founded, a correction, retraction, expression of concern or other note as may be relevant will be published in the journal.

 

DUTIES OF REVIEWERS

 

Contribution to editorial decisions

Peer review assists editors in making editorial decisions and, through editorial communications with authors, may assist authors in improving their manuscripts. Peer review is an essential component of formal scholarly communication and lies at the heart of scientific endeavor. BPASPublication shares the view of many that all scholars who wish to contribute to the scientific process have an obligation to do a fair share of reviewing.

 

Promptness

Any invited referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should immediately notify the editors and decline the invitation to review so that alternative reviewers can be contacted.

 

Scroll